Ginkgo Bioworks Holdings: Hold Rating Amidst Revenue Growth and Restructuring Efforts
In a report released yesterday, Tejas Savant from Morgan Stanley maintained a Hold rating on Ginkgo Bioworks Holdings (DNA – Research Report), ...
Business Insider18h
Balanced Hold Recommendation for Adaptive Biotechnologies Amid Positive Performance and External Challenges
Savant covers the Healthcare sector, focusing on stocks such as Myriad Genetics, Guardant Health, and Ginkgo Bioworks Holdings. According to TipRanks, Savant has an average return of -4.5% and a 40.00 ...